MIDLOTHIAN, Va., March 10 PARI's LC STAR nebulizer andPRONEB Ultra II compressor are the exclusive delivery devices for InspirePharmaceuticals' (Nasdaq: ISPH) second Phase 3 clinical trial for a ...
MIDLOTHIAN, Va., May 7, 2020 /PRNewswire/ -- This week, the first patients are enrolling in two phase 2 clinical trials for COVID-19 using Pulmotect's PUL-042, an inhaled immunomodulatory agent to ...
Respiratory devicemaker PARI picked up an approval from the FDA for its eRapid nebulizer system, which is the first electronic one to deliver Genentech's cystic fibrosis treatment Pulmozyme. A ...
Dublin, April 21, 2021 (GLOBE NEWSWIRE) -- The "Global Portable Compressor Nebulizer Market (2020-2025) by Type, Application, Distribution Channel Geography, Competitive Analysis and the Impact of ...
As highlighted in the April issue of Medical Device & Diagnostic Industry magazine, PARI Aerosol Research Institute has been awarded a 2006 Medical Design Excellence Award for eFlow. eFlow is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback